Background: A dilated orifice of the duodenal papilla found during screening endoscopy or ERCP is well-known as one of the specific findings of intraductal papillary mucinous neoplasm (IPMN). However, its clinical significance is still unclear.
Objective: To assess the diagnostic significance of a dilated orifice of the duodenal papilla and evaluate whether this could be a factor predictive of malignancy or a subtype of IPMN.
Design: Retrospective study.
Setting: University hospital.
Patients: This study involved 149 patients who underwent pancreatectomy for IPMN between January 1987 and June 2011.
Intervention: ERCP.
Main Outcome Measurements: The rate of malignant and intestinal type IPMNs in patients with and without papillary dilation.
Results: A dilated orifice of the duodenal papilla was significantly associated with intestinal type IPMN (P < .001), but this finding could not predict the malignant grade of IPMN (P = .13). Multivariate analysis revealed that a dilated orifice was a significant factor for predicting intestinal type in both main duct (P = .01) and branch duct IPMNs (P < .001).
Limitations: The validity of the definition of papillary dilation, selection bias, and a retrospective study.
Conclusion: A dilated orifice of the duodenal papilla could be a significant factor for predicting intestinal type IPMN. This may lead to better clinical management of patients with IPMN.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gie.2012.03.682 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!